ArticleCell death discovery2025

Increased efficacy of PARP inhibitors against cisplatin-sensitive and -resistant ovarian cancer cells mediated via ATR and ATM inhibition.

Philipp König et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.